• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Antimalarial sulfide, sulfone, and sulfonamide trioxanes.

作者信息

Posner G H, Maxwell J P, O'Dowd H, Krasavin M, Xie S, Shapiro T A

机构信息

Department of Chemistry, School of Arts and Sciences, The Johns Hopkins University, Baltimore, MD 21218, USA.

出版信息

Bioorg Med Chem. 2000 Jun;8(6):1361-70. doi: 10.1016/s0968-0896(00)00079-1.

DOI:10.1016/s0968-0896(00)00079-1
PMID:10896113
Abstract

A series of trioxanes featuring sulfide, sulfone, and sulfonamide substituents in diverse positions has been prepared. Structure-activity relationship (SAR) generalizations highlight two major factors controlling the antimalarial potency of these new chemical entities: (1) the proximity of the sulfur-containing substituent to the crucial peroxide bond and (2) the oxidation state of the sulfur-containing substituent. Generally, sulfones are more antimalarially potent than the corresponding sulfides.

摘要

相似文献

1
Antimalarial sulfide, sulfone, and sulfonamide trioxanes.
Bioorg Med Chem. 2000 Jun;8(6):1361-70. doi: 10.1016/s0968-0896(00)00079-1.
2
Synthesis, in vitro and in vivo antimalarial assessment of sulfide, sulfone and vinyl amide-substituted 1,2,4-trioxanes prepared via thiol-olefin co-oxygenation (TOCO) of allylic alcohols.通过烯丙醇的硫-烯烃共氧化(TOCO)合成的含硫、砜和乙烯酰胺取代的 1,2,4-三恶烷的体外和体内抗疟评估。
Org Biomol Chem. 2010 May 7;8(9):2068-77. doi: 10.1039/b924319d. Epub 2010 Mar 3.
3
Sulfide, sulfoxide and sulfone bridged acyclic nucleoside phosphonates as inhibitors of the Plasmodium falciparum and human 6-oxopurine phosphoribosyltransferases: Synthesis and evaluation.硫醚、亚砜和砜桥连的无环核苷膦酸酯作为恶性疟原虫和人 6-氧嘌呤磷酸核糖基转移酶的抑制剂:合成与评价。
Eur J Med Chem. 2019 Dec 1;183:111667. doi: 10.1016/j.ejmech.2019.111667. Epub 2019 Sep 4.
4
Synthesis and in vitro antimalarial activity of sulfone endoperoxides.
Bioorg Med Chem Lett. 1998 Apr 21;8(8):903-8. doi: 10.1016/s0960-894x(98)00141-3.
5
Preparation and antimalarial activity of a novel class of carbohydrate-derived, fused thiochromans.
Eur J Med Chem. 2014 Nov 24;87:197-202. doi: 10.1016/j.ejmech.2014.09.060. Epub 2014 Sep 19.
6
Antimalarial activity of compounds comprising a primary benzene sulfonamide fragment.包含苯磺酰胺基本片段的化合物的抗疟活性。
Bioorg Med Chem Lett. 2013 Nov 15;23(22):6114-7. doi: 10.1016/j.bmcl.2013.09.015. Epub 2013 Sep 14.
7
Comparison of the binding of 3-fluoromethyl-7-sulfonyl-1,2,3,4-tetrahydroisoquinolines with their isosteric sulfonamides to the active site of phenylethanolamine N-methyltransferase.3-氟甲基-7-磺酰基-1,2,3,4-四氢异喹啉及其等排磺酰胺与苯乙醇胺N-甲基转移酶活性位点结合的比较。
J Med Chem. 2006 Sep 7;49(18):5424-33. doi: 10.1021/jm060466d.
8
Design, Synthesis, and Biological Evaluation of Novel 1,2,4-Trioxanes as Potential Antimalarial Agents.新型1,2,4-三氧杂环己烷作为潜在抗疟药物的设计、合成及生物学评价
Arch Pharm (Weinheim). 2017 Apr;350(3-4). doi: 10.1002/ardp.201600335. Epub 2017 Feb 16.
9
Pharmacophore modeling of substituted 1,2,4-Trioxanes for quantitative prediction of their antimalarial activity.取代 1,2,4-三噁烷的药效团模型用于定量预测其抗疟活性。
J Chem Inf Model. 2010 Aug 23;50(8):1510-20. doi: 10.1021/ci100180e.
10
Electrochemical synthesis of sulfonamide derivatives based on the oxidation of 2,5-diethoxy-4-morpholinoaniline in the presence of arylsulfinic acids.基于在芳基亚磺酸存在下2,5-二乙氧基-4-吗啉基苯胺的氧化反应电化学合成磺酰胺衍生物。
J Org Chem. 2014 Jul 3;79(13):6326-9. doi: 10.1021/jo500812d. Epub 2014 Jun 19.

引用本文的文献

1
Reduction of the Double Bond of 6-Arylvinyl-1,2,4-trioxanes Leads to a Remarkable Increase in Their Antimalarial Activity against Multidrug-Resistant in a Swiss Mice Model.在瑞士小鼠模型中,6-芳基乙烯基-1,2,4-三恶烷双键的还原导致其对多重耐药疟原虫的抗疟活性显著增加。
ACS Omega. 2021 Nov 4;6(45):30790-30799. doi: 10.1021/acsomega.1c05041. eCollection 2021 Nov 16.
2
2D-quantitative structure-activity relationships model using PLS method for anti-malarial activities of anti-haemozoin compounds.采用偏最小二乘法的二维定量构效关系模型对抗疟血晶蛋白化合物的抗疟活性。
Malar J. 2021 Jun 11;20(1):264. doi: 10.1186/s12936-021-03775-2.
3
New peptide derived antimalaria and antimicrobial agents bearing sulphonamide moiety.
具有磺酰胺基部分的新型肽衍生抗疟和抗菌剂。
J Enzyme Inhib Med Chem. 2019 Dec;34(1):1388-1399. doi: 10.1080/14756366.2019.1651313.
4
A green strategy for the synthesis of sulfone derivatives of p-methylaminophenol: Kinetic evaluation and antibacterial susceptibility.一种绿色策略用于合成对甲基氨基酚的砜衍生物:动力学评估和抗菌敏感性。
Sci Rep. 2017 Jun 30;7(1):4436. doi: 10.1038/s41598-017-04581-0.
5
Synthesis and antimalarial activity of 3,3-spiroanellated 5,6-disubstituted 1,2,4-trioxanes.3,3-螺环缩合的5,6-二取代1,2,4-三恶烷的合成及其抗疟活性
ACS Med Chem Lett. 2012 Dec 11;4(2):165-9. doi: 10.1021/ml300188t. eCollection 2013 Feb 14.
6
Synthesis of five- and six-membered cyclic organic peroxides: Key transformations into peroxide ring-retaining products.五元环和六元环环状有机过氧化物的合成:保留过氧环产物的关键转化。
Beilstein J Org Chem. 2014 Jan 8;10:34-114. doi: 10.3762/bjoc.10.6.
7
Design and synthesis of new N-(5-trifluoromethyl)-1H-1,2,4-triazol-3-yl benzenesulfonamides as possible antimalarial prototypes.新型 N-(5-三氟甲基)-1H-1,2,4-三唑-3-基苯磺酰胺类抗疟原虫化合物的设计与合成。
Molecules. 2011 Sep 20;16(9):8083-97. doi: 10.3390/molecules16098083.
8
Malaria-infected mice are cured by a single oral dose of new dimeric trioxane sulfones which are also selectively and powerfully cytotoxic to cancer cells.感染疟疾的小鼠通过单次口服新型二聚三恶烷砜得以治愈,这种二聚三恶烷砜对癌细胞也具有选择性且强大的细胞毒性。
J Med Chem. 2009 Feb 26;52(4):1198-203. doi: 10.1021/jm801484v.
9
QSAR for anti-malarial activity of 2-aziridinyl and 2,3-bis(aziridinyl)-1,4-naphthoquinonyl sulfonate and acylate derivatives.2-氮丙啶基及2,3-双(氮丙啶基)-1,4-萘醌磺酸盐和酰化物衍生物抗疟活性的定量构效关系
J Mol Model. 2006 Mar;12(4):398-405. doi: 10.1007/s00894-005-0059-x. Epub 2005 Dec 9.
10
Antimalarial activity of thiophenyl- and benzenesulfonyl-dihydroartemisinin.噻吩基和苯磺酰基二氢青蒿素的抗疟活性
Korean J Parasitol. 2005 Sep;43(3):123-6. doi: 10.3347/kjp.2005.43.3.123.